Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Medicina (Kaunas) ; 59(1)2022 Dec 31.
Article in English | MEDLINE | ID: covidwho-2228828


Cardiovascular events such as myocarditis following mRNA COVID-19 vaccination are increasing. We present a 67-year-old postmenopausal woman with Takotsubo Syndrome and Graves' disease after mRNA COVID-19 vaccination. She developed chest pain and shortness of breath one week after vaccination. An electrocardiogram revealed ST elevation in the precordial leads. Coronary angiography revealed the absence of obstructive coronary artery disease, and the left ventriculography showed a typical feature with apical ballooning. Laboratory workup showed the elevation of free T4 and thyrotropin receptor antibodies. It was presumed that Takotsubo Syndrome and Graves' disease were probably related to the COVID-19 mRNA vaccination. The patient was treated with low-dose bisoprolol, diuretics, carbimazole, and steroid and discharged uneventfully. The mRNA COVID-19 vaccination is still safe and effective to defend against COVID-19 pandemic. However, clinicians should be aware of the possible cardiovascular adverse events other than myocarditis following vaccination.

COVID-19 , Graves Disease , Myocarditis , Takotsubo Cardiomyopathy , Female , Humans , Aged , COVID-19 Vaccines/adverse effects , Takotsubo Cardiomyopathy/etiology , Pandemics , Graves Disease/complications , Graves Disease/drug therapy
Circ J ; 84(11): 2023-2026, 2020 10 23.
Article in English | MEDLINE | ID: covidwho-792535


BACKGROUND: The Japanese Circulation Society proposes recommendations for all healthcare professionals involved in cardiovascular medicine to protect them from infection and ensure that seriously ill patients requiring urgent care receive proper treatment.Methods and Results:Patients are divided into "Positive or suspected coronavirus disease 2019 (COVID-19)" and "All others". Furthermore, tests and treatments are divided into emergency or standby. For each category, we propose recommendations. CONCLUSIONS: To maintain the cardiovascular care system, The Japanese Circulation Society recommends completely preventing nosocomial COVID-19 infections, ensuring adequate PPE necessary for healthcare personnel, and learning and implementing standard precautions.

Betacoronavirus/genetics , Cardiovascular Diseases/therapy , Coronavirus Infections/prevention & control , Cross Infection/prevention & control , Health Planning Guidelines , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , Coronavirus Infections/physiopathology , Coronavirus Infections/virology , Cross Infection/virology , Health Personnel , Humans , Infection Control/methods , Intubation, Intratracheal , Japan , Personal Protective Equipment , Pneumonia, Viral/physiopathology , Pneumonia, Viral/virology , Polymerase Chain Reaction , SARS-CoV-2 , Societies, Medical
Environ Health Prev Med ; 25(1): 48, 2020 Sep 05.
Article in English | MEDLINE | ID: covidwho-745686


BACKGROUND: In the wake of the coronavirus disease 2019 (COVID-19) pandemic, people need to practice social distancing in order to protect themselves from SARS-CoV-2 infection. In such stressful situations, remote cardiac rehabilitation (CR) might be a viable alternative to the outpatient CR program. METHODS: We prospectively investigated patients hospitalized for heart failure (HF) with a left ventricular ejection fraction of < 50%. As for patients who participated in the remote CR program, telephone support was provided by cardiologists and nurses who specialized in HF every 2 weeks after discharge. The emergency readmission rate within 30 days of discharge was compared among the outpatient CR, remote CR, and non-CR groups, and the EQ-5D score was compared between the outpatient CR and remote CR groups. RESULTS: The participation rate of HF patients in our remote CR program elevated during the COVID-19 pandemic. As observed in the outpatient CR group (n = 69), the emergency readmission rate within 30 days of discharge was lower in the remote CR group (n = 30) than in the non-CR group (n = 137) (P = 0.02). The EQ-5D score was higher in the remote CR group than in the outpatient CR group (P = 0.03) 30 days after discharge. CONCLUSIONS: Remote CR is as effective as outpatient CR for improving the short-term prognosis of patients hospitalized for heart failure post-discharge. This suggests that the remote CR program can be provided as a good alternative to the outpatient CR program.

Cardiac Rehabilitation/methods , Coronavirus Infections/epidemiology , Heart Failure/rehabilitation , Pneumonia, Viral/epidemiology , Self Care , Telemedicine/methods , Aged , Betacoronavirus , COVID-19 , Humans , Japan , Middle Aged , Monitoring, Ambulatory , Pandemics , Prospective Studies , SARS-CoV-2 , Telephone